Rigel Pharmaceuticals, Inc. (RIGL)
34.39
-0.35
(-1.01%)
USD |
NASDAQ |
Mar 02, 12:31
Rigel Pharmaceuticals EPS Diluted (Quarterly) : 1.456 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.875 |
| Eli Lilly & Co. | 7.024 |
| Ironwood Pharmaceuticals, Inc. | -0.014 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 27.90M |
| Revenue (Quarterly) | 69.46M |
| Total Expenses (Quarterly) | 41.56M |
| Enterprise Value | 554.31M |
| Gross Profit Margin (Quarterly) | 93.16% |
| Profit Margin (Quarterly) | 40.17% |
| Earnings Yield | 17.93% |
| Operating Earnings Yield | 18.83% |
| Normalized Earnings Yield | 17.93 |